PAHdb: A locus-specific knowledgebase

Human Mutation

Volumn 15, Issue 1, 2000, Pages 99-104

  Scriver, Charles R ^a,b   Waters, Paula J ^b   Sarkissian, Christineh ^b   Ryan, Shannon ^b   Prevost, Lynne ^b   Côté, David ^b   Novak, Jaroslav ^b   Teebi, Saeed ^b   Nowacki, Piotr M ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

MDI; Mutation database; PAH; PKU

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE;

ARTICLE; DATA BASE; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; HYPERPHENYLALANINEMIA; INFORMATION RETRIEVAL; MEDICAL INFORMATION; MOLECULAR MODEL; ONLINE SYSTEM; PHENOTYPE; PHENYLKETONURIA; PRIORITY JOURNAL;

ALLELES; ANIMALS; ARTIFICIAL INTELLIGENCE; CHROMOSOME MAPPING; DATABASES, FACTUAL; GENE EXPRESSION; GENETICS, POPULATION; HUMANS; INTERNET; MICE; MODELS, MOLECULAR; PHENOTYPE; PHENYLALANINE HYDROXYLASE;

EID: 0033986264     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P     Document Type: Article

References (37)

1. Anonymous. 1999. Newspaper and the internet: caught in the web. Economist 352:17-19.
2. Antonarakis SE and the Nomenclature Working Group. 1998. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1-13.
3. Byck S, Morgan K, Tyfield L, Dworniczak B, Scriver CR. 1994. Evidence for origin, by recurrent mutation, of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum Mol Genet 3: 1675-1677.
4. Byck S, Morgan K, Blanc L, Scriver, CR. 1996. The PAH locus and population genetic variation: the Quebec example (Abstract). Am J Hum Genet 59:A30(142).
5. Byck S, Tyfield L, Carter K, Scriver CR. 1997. Prediction of multiple hypermutable codons in the human PAH gene: codon 280 contains recurrent mutations in Quebec and other populations. Hum Mutat 9:316-321.
6. Carter KC, Byck S, Waters PJ, Richards B, Nowacki PM, Laframboise R, Lambert M, Treacy E, Scriver CR. 1998. Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: the Quebec experience. Eur J Hum Genet 6:61-70.
7. Cooper DN, Krawczak M. 1993. Human gene mutation. Oxford, UK: Bios Scientific Publishers.
8. Cotton RGH, Scriver CR. 1998. Proof of "disease-causing" mutation. Hum Mutat 12:1-3.
9. Cotton RGH, McKusick V, Scriver CR. 1998. The HUGO mutation database initiative. Science 279:10-11.
10. Degioanni A, Darlu P. 1994. Analysis of the molecular variance at the phenylalanine hydroxylase (PAH) locus. Eur J Hum Genet 2:166-176.
11. Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens RC. 1997. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nat Struct Biol 4:995-1000.
12. Erlandsen H, Stevens RC. 1999. The structural basis of phenylketonuria. Mol Genet Metab 68:103-125.
13. Fusetti F, Erlandsen H, Flatmark T, Stevens RC. 1998. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem 273:16962-16967.
14. Guldberg P, Rey F, Zschocke J, Romano C, Francois B, Michiels L, Ullrich K, Hoffman GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey J, Guttler F. 1998. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71-79.
15. Hoang L, Byck S, Prevost L, Scriver CR (curators). 1996. PAH mutation analysis consortium database: a database for disease-producing and other allelic variation in the human PAH locus. Nucleic Acids Res 24:127-131.
16. John SWM, Rozen R, Scriver CR, Laframboise R, Laberge C. 1990. Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet 46:970-974.
17. Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR. 1997. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. Am J Hum Genet 61:1309-1317.
18. Kidd JR, Pakstis AJ, Zhao H, Kidd KK. 1998. Normal variation at the phenylalanine hydroxylase locus in a global sample of human populations (Abstract). Am J Hum Genet 63:A214
19. Konecki DS, Wang Y, Trefz FK, Lichter-Konecki U, Woo SLC. 1992. Structural characterization of the 5′ region of the human phenylalanine hydroxylase gene. Biochemistry 31:8363-8368.
20. Koshland DR Jr. 1998. Conformational changes: how small is big enough. Nat Med 4:1112-1114.
21. McDonald JD, Charlton CK. 1997. Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics 39:402-405.
22. Nowacki PM. 1998. Design, development, and deployment of a locus specific mutation database: the Pahdb example. Montreal: McGill University.
23. Nowacki P, Byck S, Prevost L, Scriver CR. 1997. The PAH mutation analysis consortium database: update 1996. Nucleic Acids Res 25:139-142.
24. Nowacki PM, Byck S, Prevost L, Scriver CR. 1998. PAH mutation analysis consortium database: 1997. Prototype for relational locus-specific mutation databases. Nucleic Acids Res 26:220-225.
25. Penrose LS. 1946. Phenylketonuria. A problem in eugenics. Lancet 1:949-953.
26. Romano V. 1993. Preface to workshop on advances in phenylketonuric research. Dev Brain Dysfunct 6:9-10.
27. Sarkissian C, Shao Z, Blain F, Peevres R, Su H, Heft R, Chang TMS, Scriver CR. 1999. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc Natl Acad Sci 96:2339-2344.
28. Scriver CR, Nowacki PM. 1999. Genomics, mutations and the internet: the naming and use of parts. J Inherit Metab Dis 22:519-530.
29. Scriver CR, Waters PJ. 1999. Monogenic traits are not simple. Lessons from phenylketonuria. Trends Genet 15:267-272.
30. Scriver CR, John SMW, Rozen R, Eisensmith R, Woo SLC. 1993. Associations between populations, phenylketonuria mutations and RFLP haplotypes at the phenylalanine hydroxylase locus: an overview. Dev Brain Dysfunct 6:11-25.
31. Scriver CR, Kaufman S, Eisensmith R, Woo SLC. 1995. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 7th ed. The hyperphenylalaninemias. New York: McGraw Hill, p 1015-1075.
32. Scriver CR, Byck S, Prevost L, Hoang L, and the PAH Mutation Analysis Consortium. 1996. In: Chadwick D, Cardew G, editors. Variation in the human genome. The phenylalanine hydroxylase locus: a marker for the history of phenylketonuria and human genetic diversity. Chichester, UK: John Wiley & Sons, p 73-96.
33. Scriver CR, Nowacki PM, Lehvaslaiho H, and Working Group. 1999. Guidelines and recommendations for content, structure and deployment of mutation databases. Hum Mutat 13:344-350.
34. Shedlovsky A, McDonald JD, Smyula D, Dove WF. 1993. Mouse models of human phenylketonuria. Genetics 134:1205-1210.
35. Waters PJ, Parniak MA, Nowacki P, Scriver CR. 1998. In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function. Hum Mutat 11:14-17.
36. Zschocke J, Hoffmann GF. 1999. Phenylketonuria mutations in Germany. Hum Genet 104:390-398.
37. Zschocke J, Graham CA, Carson DJ, Nevin NC. 1995. Phenylketonuria mutation analysis in Northern Ireland: a rapid stepwise approach. Am J Hum Genet 57:1311-1317.